The groundbreaking rise of Viagra has firmly established as a example of pharmaceutical success, yet its future within the broader market now triggers questions about future yields . Alternative versions are diminishing patent protection , leading to concerns that betting on companies heavily reliant to Viagra's previous influence could be a proble